文献速递胸部肿瘤放疗放疗物理与技术

肿瘤体积变化与放疗剂量对III期非小细胞肺癌Adaptive放疗中基于4D-CT的肺通气功能的影响研究

Study on the impact of tumor volume change and radiation dose on 4D-CT-based lung ventilation function at mid-treatment adaptive radiotherapy in stage III non-small cell lung cancer.
PubMed 文献 · Radiother Oncol · 2026-01-10

结果显示,整体通气相对变化与原发灶和转移淋巴结体积相对变化呈负相关(Spearman相关系数分别为-0.625和-0.452);肿瘤缩小带来的通气恢复显著抵消了放疗引起的功能损失,而肿瘤体积缩小不明显者肺通气明显下降。高通气区域在各组中均表现为通气下降,低通气区域则改善;通气损失呈明显剂量依赖性,高通气区域在高剂量下受影响最大。

要点

  • 治疗中肺通气变化受肿瘤体积缩小显著影响,肿瘤缩小可抵消放疗引起的通气功能损失。
  • 通气损失呈剂量依赖性,高通气区域在高剂量下受损最明显,应优先保护。
  • 建议将肿瘤体积缩小因素纳入Adaptive再计划,以优化肺功能保护。

核心结论

  • 治疗中肺通气变化受肿瘤体积缩小显著影响,肿瘤缩小引起的通气恢复可抵消放疗所致功能损失。
  • 高通气区域存在明确剂量依赖性功能损失,高放疗剂量抑制肺通气。
  • 应重视保护非小细胞肺癌放疗中的高通气肺区域,并考虑将肿瘤体积缩小纳入Adaptive再计划。

研究设计与样本

  • 于治疗前和治疗中行4D-CT扫描,按原发灶和转移淋巴结体积相对变化分组比较。
  • 将治疗前肺通气图分为高、中、低通气区域,与按累积肺剂量划分的四个剂量区相交分析。

主要发现

  • 整体通气相对变化与原发灶体积相对变化呈负相关,Spearman相关系数为-0.625。
  • 整体通气相对变化与转移淋巴结体积相对变化呈负相关,Spearman相关系数为-0.452。
  • 几乎所有患者组均表现为高通气区域通气下降、低通气区域改善。
  • 通气损失在所有区域呈明显剂量依赖性,无显著肿瘤缩小驱动通气恢复者高通气区域受影响最大。

临床怎么用

  • Adaptive放疗再计划时应评估肿瘤体积缩小对肺通气恢复的潜在贡献。
  • 制定肺剂量约束时优先保护高通气区域,以降低剂量依赖性通气损失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to evaluate the impact of tumor volume reduction at mid-treatment on four-dimensional computed tomography (4D-CT) based lung ventilation function for patients with lung cancer undergoing adaptive radiotherapy (ART), and explores the relationship between radiation dose and ventilation loss to inform personalized lung dose optimization in radiotherapy planning. MATERIALS AND METHODS: Forty patients with stage III non-small cell lung cancer (NSCLC) who had undergone ART were enrolled. 4D-CT scans were performed at pre- and mid-treatment. Patients were categorized according to the relative volume changes in primary gross tumor volume (GTVp) and nodal gross tumor volume (GTVn). Each metric was used to divide the cohort into three groups, yielding a total of six comparative groups. Pre-treatment lung ventilation maps, divided into high-, medium-, and low-ventilation regions, were intersected with four dose zones that were categorized by the cumulative lung dose. Ventilation changes at mid-treatment ART in these ventilation regions and dose zones were analyzed for each patient group. RESULTS: Negative correlations were observed between relative changes in the overall ventilation and relative volume changes of the two target contours (GTVp and GTVn), with Spearman correlation coefficients being -0.625 and -0.452, respectively. Ventilation recovery resulting from tumor shrinkage significantly counteracted radiation-induced functional loss. In contrast, patients with minimal tumor volume reduction showed marked declines in pulmonary ventilation. Nearly all patient groups exhibited ventilation reduction in the high-ventilation region and improvement in the low-ventilation region.Ventilation loss showed a clear dose-dependent pattern across all regions, with the high-ventilation region most affected in patients without significant tumor-shrinkage-driven ventilation recovery. CONCLUSIONS: Changes in lung ventilation at mid-treatment were strongly influenced by tumor volume reduction. A clear dose-dependent functional loss pattern was confirmed in the high-ventilation region, with high radiation doses inhibiting lung ventilation. These findings underscore the importance of protecting high-ventilation lung in NSCLC radiotherapy and suggest incorporating tumor volume reduction into adaptive re-planning.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Deng G, Ding J, Zhu J, et al. Study on the impact of tumor volume change and radiation dose on 4D-CT-based lung ventilation function at mid-treatment adaptive radiotherapy in stage III non-small cell lung cancer. Radiother Oncol. 2026. PMID: 41525978. doi:10.1016/j.radonc.2026.111383

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。